Yale researchers provide new insights into acquired resistance to cancer immunotherapy April 19, 2021 New research by Yale Cancer Center shows insights into modeling resistance to immune checkpoint inhibitors, a form of cancer immunotherapy. The study was presented today at the American Association of Cancer Research (AACR) virtual annual meeting.Read the full article here. Source: Emily Henderson - News Medical Prostate Cancer News
New research by Yale Cancer Center shows insights into modeling resistance to immune checkpoint inhibitors, a form of cancer immunotherapy. The study was presented today at the American Association of Cancer Research (AACR) virtual annual meeting.Read the full article here. Source: Emily Henderson - News Medical
